Genzyme (GENZ) Reports Q3 Miss; Narrows Q4 EPS Outlook

October 20, 2010 9:24 AM EDT
Get Alerts GENZ Hot Sheet
Trade GENZ Now!
Join SI Premium – FREE
Genzyme (NYSE: GENZ) Reports Q3 EPS of $0.42, ex-items, 9 cents lower than the analyst estimate of $0.53. Revenue for the quarter was $1 billion, which compares to the estimate of $1.1 billion.

Narrows Q4 adj-EPS outlook from $0.90-$1 to 90-95c, vs. the consensus of 88c. Sees cerezyme $235-$245 million, fabrazyme sales of $70-$75 million.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance, Hot List

Add Your Comment